• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Swedish Orphan Biovitrum AB

+ Add to Watchlist

B6E:GR

8.054 EUR 0.112 1.37%

As of 15:15:41 ET on 12/23/2014.

Snapshot for Swedish Orphan Biovitrum AB (B6E)

Open: 8.249 Day's Range: 8.054 - 8.249 Volume: 0
Previous Close: 8.166 52wk Range: 7.100 - 10.150 1-Yr Rtn: +9.89%

Stock Chart for B6E

No chart data available.
  • B6E:GR 8.177
  • 1D
  • 1M
  • 1Y
8.166
Interactive B6E Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B6E

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 184.2330
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.4180
Est. PEG Ratio -
Market Cap (M EUR) 2,221.06
Shares Outstanding (M) 270.39
30 Day Average Volume 15
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B6E

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for B6E

Swedish Orphan Biovitrum AB is a biomedical company. The Company develops and makes available orphan drugs and niche specialty pharmaceuticals for patients with rare diseases and with high unmet medical needs.

Geoffrey McDonoughChief Executive OfficerMats-Olof WallinSenior VP/CFO
Alan RaffenspergerSenior VP/COOBirgitte VolckSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for B6E

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil